Clinical trial

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic…

NCT00140829 · Institut National de la Santé Et de la Recherche Médicale, France, Other · Completed

Key facts

NCT number NCT00140829
Title SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Official title Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Acronym Spatax
Lead sponsor Institut National de la Santé Et de la Recherche Médicale, France, Other
Collaborators Institut des Maladies Rares National Research Agency, France Paris Brain Institute (ICM)
Status Completed
Study type Observational
Conditions Cerebellar Ataxias, Spastic Paraplegias
Enrollment 6,000
Start date Feb 10, 2004
Primary completion Dec 1, 2020
Completion Dec 30, 2020
First posted Sep 1, 2005
Last update posted Feb 4, 2025
Countries Algeria, Belgium, Denmark, France, Israel, Italy, Lebanon, Morocco, Netherlands, Norway, Portugal, Saudi Arabia and 3 more

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies